An at-home test designed to help individuals identify birth control options that may limit potential side effects has been made available by adyn.

The Birth Control Test was created to help assess an individual’s risk for certain birth control side effects through hormone measurements and genetic analysis. The test measures the levels of 6 specific hormones: anti-Müllerian hormone (AMH), E2 (17𝛽-estradiol), sex hormone-binding globulin (SHBG), follicle-stimulating hormone (FSH), luteinizing hormone (LH), and dehydroepiandrosterone sulfate (DHEA-S). It also provides information on genetic risk for birth control side effects, including blood clots and depression.

“Fifty two percent of women have tried 4 or more birth control methods (not including different types of the pill) before they are satisfied,” said founder and CEO Dr Elizabeth Ruzzo, PhD. “My firsthand experience with life threatening side effects from birth control, coupled with my scientific background, inspired me to find a solution for this problem.”

The test is shipped directly to an individual’s home where a small finger prick of blood is collected to measure hormones and a saliva sample is collected for DNA analysis. Once the samples are analyzed via CLIA/CAP accredited facilities, a personalized report is generated to identify an individual’s risks for certain side effects. A virtual care visit is then scheduled with a medical provider trained in contraceptive counseling to determine appropriate birth control options.  

The Birth Control Test was developed based on the Centers for Disease Control and Prevention’s (CDC’s) medical eligibility criteria for contraceptive use and has not been reviewed by the Food and Drug Administration (FDA). According to the FDA, “in general, direct-to-consumer tests for non-medical, general wellness, or low risk medical purposes are not reviewed […] before they are offered.”

 The test is available nationwide (except New York, New Jersey, Rhode Island) for $369 at The cost includes the at-home collection materials, analysis, personalized reporting, and a virtual care visit. 


  1. Adyn launches first test designed to prevent birth control side effects. News release. Adyn, Inc. Accessed May 23, 2022.
  2. In vitro diagnostics: direct-to-consumer tests. US Food and Drug Administration. Accessed May 23, 2022.
  3. Services: The Birth Control Test. Adyn, Inc.